These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 9005780)
1. [Antimicrobial activity and action mechanism of ofloxacin]. Padeĭskaia EN Antibiot Khimioter; 1996; 41(9):13-23. PubMed ID: 9005780 [No Abstract] [Full Text] [Related]
2. [Mechanisms of resistance to quinolones and current level of sensitivity of clinically important microorganisms to ofloxacin]. Sidorenko SV; Rezvan SP; Makarova RA; Makarov AN; Kozlova NS; Ogneva NS; Korolev IuS; Gladin DP Antibiot Khimioter; 1996; 41(9):33-8. PubMed ID: 9005782 [TBL] [Abstract][Full Text] [Related]
3. [In vitro and in vivo antibacterial activities of a new quinolone derivative, FD501]. Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y Jpn J Antibiot; 1996 Mar; 49(3):264-72. PubMed ID: 8935122 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays. Wu P; Lawrence LE; Denbleyker KL; Barrett JF Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365 [TBL] [Abstract][Full Text] [Related]
5. Chemical composition and antimicrobial activity of the essential oil of Scutellaria barbata. Yu J; Lei J; Yu H; Cai X; Zou G Phytochemistry; 2004 Apr; 65(7):881-4. PubMed ID: 15081288 [TBL] [Abstract][Full Text] [Related]
6. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels. Kowalski RP; Karenchak LM; Gordon YJ Cornea; 1998 May; 17(3):282-7. PubMed ID: 9603384 [TBL] [Abstract][Full Text] [Related]
7. 6-hydroxy derivative as new desfluoroquinolone (DFQ): synthesis and DNA-binding study. Tabarrini O; Sissi C; Fravolini A; Palumbo M Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1327-36. PubMed ID: 11097062 [TBL] [Abstract][Full Text] [Related]
8. [Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance]. Budanov SV; Smirnova LB Antibiot Khimioter; 2001; 46(5):31-8. PubMed ID: 11558453 [No Abstract] [Full Text] [Related]
9. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery. Yu-Speight AW; Kern TJ; Erb HN Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria. Moros M; Coll R; Esteve M; Parés J; Xicota MA Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373 [No Abstract] [Full Text] [Related]
11. [Use of ofloxacin in infections which do not readily respond to treatment]. Zalaudek G Antibiot Khimioter; 1996; 41(9):11-2. PubMed ID: 9005779 [TBL] [Abstract][Full Text] [Related]